The complement inhibitors market is projected to grow, driven by the rising prevalence of complement-mediated diseases, intensified R&D efforts, and biotechnological advancements enabling novel ...

Before you tweak the recipe, it’s best to learn the classic. And the classic starts with a simple question: bourbon or rye?

Perivascular adipose tissue (PVAT) has emerged as a significant player in the regulation of vascular health, complementing ...

EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced p ...

Bean salads are hearty and flavorful. If you need some ideas for your next batch, check out some of our favorite bean salad ...

It often takes stepping outside India to notice what we overlook at home, for instance, identifying clues to better nutrition ...

Karan Mahajan’s new novel, “The Complex,” tracks the fortunes of a political family in a rapidly changing India. By Jonathan Dee Jonathan Dee is the author of eight novels, most recently “Sugar Street ...

C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare and progressive kidney diseases, caused by problems in the immune system. They are two distinct ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

Results from CADENCE, the first and largest multinational prospective registry for patients with CAD/CAS, describe safety events observed in patients treated with sutimlimab, with an average treatment ...

Add Yahoo as a preferred source to see more of our stories on Google. Leaders of an effort to finance a $16.7 million renovation of Joplin’s Memorial Hall told residents during a Monday night ...